Developing implants to improve joint repair in osteoarthritis patients
Official title: Addressing bone marrow lesions that compromise osteochondral tissue repair
Funded at Cytex Therapeutics INC. · NIH-10822755 · Data updated 2026-11-12
This study is testing new 3D-printed implants that help heal cartilage and bone for people with osteoarthritis, aiming to improve recovery and joint function after surgery.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cytex Therapeutics INC. NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project start | September 18, 2023 |
| Project end | August 31, 2025 |
| Funding year | 2023 |
| Award (this year) | $282,265 |
| NIH project number | 1R41AR083778-01 |
| Project ID | NIH-10822755 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are adults under 65 years old who are experiencing osteoarthritis and are seeking alternatives to joint replacement surgery.
✕Less likely to help
Patients with advanced osteoarthritis who are not candidates for surgical intervention or those who have already undergone multiple joint surgeries may not benefit from this research.
What this research studies
This research focuses on creating innovative implants that utilize advanced 3D weaving technology to enhance the regeneration of cartilage and bone in patients suffering from osteoarthritis. The implants are designed to support joint function immediately after surgery and promote the integration of new osteochondral tissue. By addressing common complications such as bone marrow lesions and inflammation that hinder recovery, this approach aims to improve long-term outcomes for patients. The research involves testing these implants in large animal models to evaluate their effectiveness before potential human application.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for osteoarthritis, reducing pain and improving mobility for millions of patients.
How similar studies have gone: Previous research has shown promising results with similar implant technologies in animal models, indicating potential for success in human applications.
Where this research is happening
-
Cytex Therapeutics INC.
Durham, United States Active
Researchers
- Principal investigator: Willard, Vincent P — Cytex Therapeutics INC.
- Study coordinator: Willard, Vincent P
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.